🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
MKC-NI-002 is a Phase 1b, randomized, double-blind, placebo-controlled stud...
Status
Completed
Location
VALDI
Start Date
2025-12-22
Trial ID
NCT07344558
Treatments Being Tested
Batefenterol is a novel bifunctional molecule that combines muscarinic anta...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-11-06
Trial ID
NCT02570165
Treatments Being Tested
This is a randomized, single-blind, placebo-controlled, sequential-group st...
Status
Completed
Location
Research Site
Start Date
2016-01-12
Trial ID
NCT02645253
The purpose of this study is to evaluate the efficacy of Fixed Combination ...
Status
Completed
Location
Medical Center Convex EOOD
Start Date
2018-06-15
Trial ID
NCT03590379
Treatments Being Tested
This study will evaluate the efficacy and safety data of AZD8871 in patient...
Status
Completed
Location
Research Site
Start Date
2018-10-10
Trial ID
NCT03645434
Treatments Being Tested
The overall objective of this study is to determine an optimal dose and dos...
Status
Completed
Location
Pearl Investigative Site
Start Date
2012-03
Trial ID
NCT01566773
Treatments Being Tested
This study is a 12-week, multicenter, randomized, double blind, parallel gr...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-09-01
Trial ID
NCT02152605
To assess the bronchodilation of three doses of formoterol fumarate (6 μg, ...
Status
Completed
Location
Research Site
Start Date
2016-06-30
Trial ID
NCT02796651
This randomized, cross over study aims to find out the benefits of deliveri...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-09-20
Trial ID
NCT03227445
Treatments Being Tested
GSK233705 is a high-affinity specific muscarinic receptor (mAChR) antagonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-12-12
Trial ID
NCT00279019
Treatments Being Tested